Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1992;86:1125-1137

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perrone-Filardi, P.
Right arrow Articles by Bonow, R. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perrone-Filardi, P.
Right arrow Articles by Bonow, R. O.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*2-DEOXY-D-GLUCOSE
Medline Plus Health Information
*MRI Scans

Circulation, Vol 86, 1125-1137, Copyright © 1992 by American Heart Association


ARTICLES

Regional left ventricular wall thickening. Relation to regional uptake of 18fluorodeoxyglucose and 201Tl in patients with chronic coronary artery disease and left ventricular dysfunction

P Perrone-Filardi, SL Bacharach, V Dilsizian, S Maurea, JA Frank and RO Bonow
Cardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md.

BACKGROUND. In previous studies comparing regional 201Tl (201Tl) and 18fluorodeoxyglucose (FDG) activity in patients with chronic coronary artery disease and left ventricular dysfunction, we hypothesized that regions with mild-to-moderate reduction in FDG activity and regions with mild-to-moderate irreversible 201Tl defects after 3- to 4-hour redistribution represent viable myocardium. In the present study, regional FDG and 201Tl activities were compared with regional systolic wall thickening by gated magnetic resonance imaging (MRI) to confirm the presence of viable myocardium in these territories. METHODS AND RESULTS. Twenty-five patients with chronic stable coronary artery disease and left ventricular dysfunction (ejection fraction, 28 +/- 10) underwent exercise 201Tl tomographic imaging (SPECT), using a reinjection protocol, positron emission tomography (PET) with FDG and H2(15)O, and gated MRI. Matched SPECT, PET, and MRI tomograms were analyzed. From the PET data, 105 regions had matched reduction in FDG and blood flow, of which 69 regions had moderately reduced FDG uptake (50-79% uptake relative to a normal reference region) and 36 had severely reduced FDG uptake (less than 50% of normal activity). Regions with moderately reduced as compared with severely reduced FDG activity had greater end-diastolic wall thickness (9.4 +/- 2.6 versus 8.0 +/- 3.7 mm; p less than 0.05) and regional systolic wall thickening (1.7 +/- 2.7 versus -0.7 +/- 2.1 mm; p less than 0.01). From the SPECT data, 169 irreversible 201Tl defects after 3-4 hour redistribution were identified, of which 70 were mild (greater than 65 to less than 85% of maximal 201Tl activity), 52 were moderate (50-65% of maximal activity), and 47 were severe (less than 50% of maximal activity). Regional systolic wall thickening was greater in regions with normal 201Tl uptake (3.3 +/- 2.3 mm) as compared with all other regions. Regions showing only mild or moderate irreversible defects at redistribution, however, showed wall thickening (2.4 +/- 2.4 and 2.2 +/- 2.5 mm, respectively), which was similar to that observed in regions with reversible 201Tl defects (2.1 +/- 2.2 mm). Only regions with severe irreversible defects at redistribution showed absence of thickening (- 0.1 +/- 2.9 mm, p less than 0.01 versus all other groups). After 201Tl reinjection, 12 of 47 (26%) regions with severe irreversible defects showed enhanced 201Tl uptake. The impairment in regional systolic wall thickening was not significantly different between 201Tl defects with and without enhanced 201Tl uptake after reinjection. FDG activity, however, was present in all 12 regions (100%) with enhanced 201Tl uptake after reinjection as compared with only five of 35 (14%) that were unchanged after reinjection (p less than 0.01). CONCLUSIONS. Therefore, preserved wall thickness and systolic wall thickening in regions with moderate reduction in blood flow and FDG activity, and in irreversible 201Tl defects that are only mild-to-moderate, provide additional evidence that such regions represent viable myocardium. Moreover, the finding of metabolic activity and 201Tl uptake in regions with reduced blood flow and absent wall thickening provides clinical evidence of hibernating myocardium in humans.


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. G. Barra, A. J. Crottogini, P. Willshaw, E. C. Lascano, and R. H. Pichel
Contribution of myocardium hydraulic skeleton to left ventricular wall interaction and synergy in dogs
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H896 - H904.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
L. Van Hoe and M. Vanderheyden
Ischemic Cardiomyopathy: Value of Different MRI Techniques for Prediction of Functional Recovery After Revascularization
Am. J. Roentgenol., January 1, 2004; 182(1): 95 - 100.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Murashita, Y. Makino, Y. Kamikubo, K. Yasuda, M. Mabuchi, and N. Tamaki
Quantitative gated myocardial perfusion single photon emission computed tomography improves the prediction of regional functional recovery in akinetic areas after coronary bypass surgery: useful tool for evaluation of myocardial viability
J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1328 - 1334.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M Egred, A Al-Mohammad, G D Waiter, T W Redpath, S K Semple, M Norton, A Welch, and S Walton
Detection of scarred and viable myocardium using a new magnetic resonance imaging technique: blood oxygen level dependent (BOLD) MRI
Heart, July 1, 2003; 89(7): 738 - 744.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Klein, S. G. Nekolla, F. M. Bengel, M. Momose, A. Sammer, F. Haas, B. Schnackenburg, W. Delius, H. Mudra, D. Wolfram, et al.
Assessment of Myocardial Viability With Contrast-Enhanced Magnetic Resonance Imaging: Comparison With Positron Emission Tomography
Circulation, January 15, 2002; 105(2): 162 - 167.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
G. D WAITER, A. AL-MOHAMMAD, M. Y NORTON, T. W REDPATH, A. WELCH, and S. WALTON

Heart, September 1, 2000; 84(3): 332 - 333.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. M. Cwajg, E. Cwajg, S. F. Nagueh, Z.-X. He, U. Qureshi, L. I. Olmos, M. A. Quinones, M. S. Verani, W. L. Winters, and W. A. Zoghbi
End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation: Relation to rest-redistribution Tl-201 tomography and dobutamine stress echocardiography
J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1152 - 1161.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
Y. Cottin, C. Touzery, F. Guy, A. Lalande, O. Ressencourt, S. Roy, P. M. Walker, P. Louis, F. Brunotte, and J. E. Wolf
MR Imaging of the Heart in Patients after Myocardial Infarction: Effect of Increasing Intersection Gap on Measurements of Left Ventricular Volume, Ejection Fraction, and Wall Thickness
Radiology, November 1, 1999; 213(2): 513 - 520.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. D. Costa, Y. Takayama, A. D. McCulloch, and J. W. Covell
Laminar fiber architecture and three-dimensional systolic mechanics in canine ventricular myocardium
Am J Physiol Heart Circ Physiol, February 1, 1999; 276(2): H595 - H607.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Ramani, R. M. Judd, T. A. Holly, T. B. Parrish, V. H. Rigolin, M. A. Parker, C. Callahan, S. W. Fitzgerald, R. O. Bonow, and F. J. Klocke
Contrast Magnetic Resonance Imaging in the Assessment of Myocardial Viability in Patients With Stable Coronary Artery Disease and Left Ventricular Dysfunction
Circulation, December 15, 1998; 98(24): 2687 - 2694.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Srinivasan, A. N. Kitsiou, S. L. Bacharach, M. L. Bartlett, C. Miller-Davis, and V. Dilsizian
[18F]Fluorodeoxyglucose Single Photon Emission Computed Tomography : Can It Replace PET and Thallium SPECT for the Assessment of Myocardial Viability?
Circulation, March 10, 1998; 97(9): 843 - 850.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
M.G. Niemeyer, A.F.M. Kuijper, J.G. Meeder, M.J.M. Cramer, A.J.M. Cleophas, E.E. van der Wall, and M. G. Niemeyer
Comparison of Thallium Scintigraphy and Positron Emission Tomography
Angiology, October 1, 1997; 48(10): 843 - 853.
[Abstract] [PDF]


Home page
CirculationHome page
P. Perrone-Filardi, L. Pace, M. Prastaro, F. Squame, S. Betocchi, A. Soricelli, F. Piscione, C. Indolfi, T. Crisci, M. Salvatore, et al.
Assessment of Myocardial Viability in Patients With Chronic Coronary Artery Disease: Rest–4-Hour–24-Hour 201Tl Tomography Versus Dobutamine Echocardiography
Circulation, December 1, 1996; 94(11): 2712 - 2719.
[Abstract] [Full Text]


Home page
CirculationHome page
M. Berman, A. J. Fischman, J. Southern, E. Carter, F. Mirecki, H. W. Strauss, A. Nunn, and H. Gewirtz
Myocardial Adaptation During and After Sustained, Demand-Induced Ischemia: Observations in Closed-Chest, Domestic Swine
Circulation, August 15, 1996; 94(4): 755 - 762.
[Abstract] [Full Text]


Home page
CirculationHome page
J.-L. J. Vanoverschelde, B. L. Gerber, A.-M. D'Hondt, M. De Kock, R. Dion, W. Wijns, and J. A. Melin
Preoperative Selection of Patients With Severely Impaired Left Ventricular Function for Coronary Revascularization : Role of Low-Dose Dobutamine Echocardiography and Exercise-Redistribution-Reinjection Thallium SPECT
Circulation, November 1, 1995; 92(9): 37 - 44.
[Abstract] [Full Text]


Home page
CirculationHome page
E. E. van der Wall, H. W. Vliegen, A. de Roos, and A. V.G. Bruschke
Magnetic Resonance Imaging in Coronary Artery Disease
Circulation, November 1, 1995; 92(9): 2723 - 2739.
[Abstract] [Full Text]


Home page
CirculationHome page
P. Perrone-Filardi, L. Pace, M. Prastaro, F. Piscione, S. Betocchi, F. Squame, P. Vezzuto, A. Soricelli, C. Indolfi, M. Salvatore, et al.
Dobutamine Echocardiography Predicts Improvement of Hypoperfused Dysfunctional Myocardium After Revascularization in Patients With Coronary Artery Disease
Circulation, May 15, 1995; 91(10): 2556 - 2565.
[Abstract] [Full Text]


Home page
CirculationHome page
J. A. Panza, V. Dilsizian, J. M. Laurienzo, R. V. Curiel, and P. T. Katsiyiannis
Relation Between Thallium Uptake and Contractile Response to Dobutamine : Implications Regarding Myocardial Viability in Patients With Chronic Coronary Artery Disease and Left Ventricular Dysfunction
Circulation, February 15, 1995; 91(4): 990 - 998.
[Abstract] [Full Text]


Home page
CirculationHome page
F. M. Baer, E. Voth, C. A. Schneider, P. Theissen, H. Schicha, and U. Sechtem
Comparison of Low-Dose Dobutamine–Gradient-Echo Magnetic Resonance Imaging and Positron Emission Tomography With [18F]Fluorodeoxyglucose in Patients With Chronic Coronary Artery Disease : A Functional and Morphological Approach to the Detection of Residual Myocardial Viability
Circulation, February 15, 1995; 91(4): 1006 - 1015.
[Abstract] [Full Text]